Activating Transcription Factor 3 Regulates in Part the Enhanced Tumour Cell Cytotoxicity of the Histone Deacetylase Inhibitor M344 and Cisplatin in Combination

Cancer Cell International - United Kingdom
doi 10.1186/1475-2867-10-32
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Transcription Factor Erg Regulates Expression of Histone Deacetylase 6 and Multiple Pathways Involved in Endothelial Cell Migration and Angiogenesis

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Activating Transcription Factor 3 Regulates Canonical TGFβ Signalling in Systemic Sclerosis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2015English

Activated Transcription Factor 3 in Association With Histone Deacetylase 6 Negatively Regulates MicroRNA 199a2 Transcription by Chromatin Remodeling and Reduces Endothelin-1 Expression

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2016English

The Histone Deacetylase Inhibitor SAHA Arrests Cancer Cell Growth, Up-Regulates Thioredoxin-Binding Protein-2, and Down-Regulates Thioredoxin

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2002English

486 Histone Deacetylase 3 Regulates the Ontogeny and Maintenance of Tissue-Resident Macrophages

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824

Cancer Research
Cancer ResearchOncology
2009English

Histone Deacetylase Inhibitor, Valproic Acid, Radiosensitizes the C6 Glioma Cell Line in Vitro

Oncology Letters
Cancer ResearchOncology
2013English

Superior Activity of the Combination of Histone Deacetylase Inhibitor LAQ824 and the FLT-3 Kinase Inhibitor PKC412 Against Human Acute Myelogenous Leukemia Cells With Mutant FLT-3

Clinical Cancer Research
Cancer ResearchOncology
2004English

Enhanced Cisplatin Response With Histone Acetyl Transferase Inhibitor, Anacardic Acid, in Malignant Pleural Mesothelioma Cell Line

Turkiye Klinikleri Journal of Medical Sciences
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy